Related Experiment Video
Updated: May 11, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Cbl-b mediates TGFβ sensitivity by downregulating inhibitory SMAD7 in primary T cells
Thomas Gruber1, Reinhard Hinterleitner, Natascha Hermann-Kleiter
1Department for Pharmacology and Genetics, Medical University of Innsbruck, Innsbruck, Austria.
Abstract:
T cell-intrinsic transforming growth factor β (TGFβ) receptor signaling plays an essential role in controlling immune responses. The RING-type E3 ligase Cbl-b has been shown to mediate the sensitivity of T cells to TGFβ; however, the mechanism underlying this process is unknown. This study shows that SMAD7, an established negative regulator of TGFβ receptor (TGFβR) signaling, is a key downstream effector target of Cbl-b. SMAD7 protein levels, but not SMAD7 mRNA levels, are upregulated in cblb(-/-) T cells. Cbl-b directly interacts with and ubiquitinates SMAD7, suggesting that Cbl-b posttranscriptionally regulates SMAD7. In support of this notion, concomitant genetic loss of SMAD7 in cblb(-/-) mice restored TGFβ sensitivity on T cell cytokine responses and abrogated the tumor rejection phenotype of cblb(-/-) mice. These results demonstrate an essential and non-redundant role for Cbl-b in controlling TGFβR signaling by directly targeting SMAD7 for degradation during T cell responses in vitro and in vivo.
Insights
The E3 ligase Cbl-b controls T cell responses to transforming growth factor beta (TGFβ) by targeting SMAD7 for degradation. This mechanism is crucial for immune regulation and tumor rejection.
Area of Science:
- Immunology
- Molecular Biology
- Cell Signaling
Background:
- T cell-intrinsic transforming growth factor beta (TGFβ) receptor signaling is vital for immune response regulation.
- The E3 ligase Cbl-b influences T cell sensitivity to TGFβ, but the underlying mechanism remains unclear.
Purpose of the Study:
- To elucidate the mechanism by which Cbl-b regulates TGFβ receptor (TGFβR) signaling in T cells.
- To identify downstream targets of Cbl-b involved in TGFβ sensitivity.
Main Methods:
- Investigated SMAD7 protein and mRNA levels in Cbl-b deficient (cblb(-/-)) T cells.
- Assessed direct interaction and ubiquitination of SMAD7 by Cbl-b.
- Utilized genetic knockout models (cblb(-/-) and SMAD7 loss) in mice to evaluate T cell responses and tumor rejection.
Main Results:
- SMAD7 protein levels, not mRNA, were elevated in cblb(-/-) T cells, indicating posttranscriptional regulation.
- Cbl-b directly ubiquitinates SMAD7, promoting its degradation.
- Loss of SMAD7 in cblb(-/-) mice restored TGFβ sensitivity and abolished tumor rejection.
Conclusions:
- Cbl-b directly targets SMAD7 for degradation, revealing a novel mechanism for controlling TGFβR signaling in T cells.
- This Cbl-b-SMAD7 pathway plays a critical, non-redundant role in T cell immune responses and tumor immunity.
Related Concept Videos
TGF - β Signaling Pathway
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Hedgehog Signaling Pathway
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...

